Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,017,878
+$943,053 QoQ
Shares Held
659,575
+1.8% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,291,958,108 across 423 Biotechnology names. DSGN ranks #178 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in DSGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,017,878 | 659,575 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,074,825 | 647,636 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,777,009 | 634,397 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,423,744 | 719,212 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,756,325 | 714,074 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,462,878 | 723,319 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,716,643 | 690,826 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,329,667 | 695,423 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,816,913 | 698,986 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,842,343 | 695,224 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,634,826 | 692,723 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,692,020 | 586,035 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,105,516 | 711,528 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $31,164,339 | 3,037,460 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $15,206,321 | 909,469 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $6,296,934 | 449,781 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,517,187 | 403,541 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,327,808 | 342,261 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,108,521 | 211,608 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,741,090 | 188,089 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||